June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Test-retest repeatability of a reduced density central visual field test
Author Affiliations & Notes
  • Gary C Lee
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Collins Opoku-Baah
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Luke Chong
    School of Medicine (Optometry), Deakin University, Geelong, Victoria, Australia
  • Buck Cunningham
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Thomas Callan
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • John G Flanagan
    Herbert Wertheim School of Optometry and Vision Science, University of California Berkeley, Berkeley, California, United States
  • Footnotes
    Commercial Relationships   Gary Lee Carl Zeiss Meditec, Inc., Code E (Employment); Collins Opoku-Baah Carl Zeiss Meditec, Inc., Heru, Inc., Code E (Employment); Luke Chong Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Inc., Code F (Financial Support); Buck Cunningham Carl Zeiss Meditec, Inc., Code E (Employment); Thomas Callan Carl Zeiss Meditec, Inc., Code E (Employment); John Flanagan Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Inc., Code F (Financial Support)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5108. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gary C Lee, Collins Opoku-Baah, Luke Chong, Buck Cunningham, Thomas Callan, John G Flanagan; Test-retest repeatability of a reduced density central visual field test. Invest. Ophthalmol. Vis. Sci. 2023;64(8):5108.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Goldmann Size V visual field (VF) stimuli were previously shown to potentially have clinical utility in detecting glaucomatous defects, even in early glaucoma [1]. One way to use larger stimuli may be to use fewer points in testing the VF. This ongoing, preliminary clinical study compared the repeatability of the locations in a prototype Size V reduced density central VF test to a reference Size V 10-2 test in healthy and glaucomatous eyes.

Methods : Size V VFs for a custom, reduced density central test pattern (32 points; see Fig. 1) paired with the Full Threshold (FT) strategy and a reference Size V 10-2 FT test (64 points) were acquired at each of two visits within 3 months for healthy and glaucomatous subjects on an HFA3 Model 840 (ZEISS, Dublin, CA). Visit 1 Mean Deviations (MD) from Size III FT 10-2 VFs also acquired at each visit were used as a reference for disease severity. Size V reference limits for normality were interpolated from a previous study [1]. Repeatability for the tests was calculated by computing test-retest standard deviations (TRT-SD) from both visit data for MD and pooled individual threshold values.

Results : For 32 healthy eyes (31 subjects), mean age was 52.3 (standard deviation, SD: 14.5; range: 27.7 to 79.2) years and mean 10-2 FT Size III MD was 0.23 (SD: 1.45; range: -2.86 to 2.61) dB. For 18 glaucoma eyes (16 subjects), mean age was 77.7 (SD: 5.3; range 63.2 to 87.6) years and mean 10-2 FT MD was -8.78 (SD: 7.18; range: -29.18 to -0.93) dB. Three fellow eyes were tested and treated as independent eyes. TRT-SDs and 95% confidence intervals (CI) for MD were 0.78 [0.55, 0.96] and 0.69 [0.49, 0.84] dB for reference and reduced patterns, respectively. Fig. 2 shows TRT-SDs for reduced pattern thresholds were also comparable to the reference pattern.

Conclusions : The findings in this preliminary study suggest the repeatability of the test locations in the reduced test pattern are comparable to the reference 10-2 test pattern. As a result, a visual field test utilizing this pattern with Size V stimuli to test fewer locations may maintain comparable ability to detect progressive local changes in a given test location in the central visual field as compared to the current 10-2 test pattern.

[1] Flanagan et al. IOVS 2016; 57(12).

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Figure 1. Example reduced test pattern

Figure 1. Example reduced test pattern

 

Figure 2. TRT-SD and 95% confidence intervals of pooled, binned thresholds from reference and reduced test patterns

Figure 2. TRT-SD and 95% confidence intervals of pooled, binned thresholds from reference and reduced test patterns

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×